Alzheimer's disease a century later
- PMID: 17196061
- DOI: 10.4088/jcp.v67n1118
Alzheimer's disease a century later
Abstract
Objective: To provide a current survey of the clinical and pathologic features, known genetic and suggested pathogenic contributions, diagnosis, and treatment of Alzheimer's disease (AD) and related forms of dementia.
Data sources: PubMed was searched for specific indexing terms identified by the authors as relevant to the topic. Also included were diagnostic and consensus criteria and classic references long standing in the Alzheimer's disease literature.
Data synthesis: AD is the most common form of disabling cognitive impairment in older persons, and its prevalence is rapidly growing as people live to older ages. Clinically, the disorder is characterized by a gradual but progressive decline in memory and other cognitive domains and the frequent occurrence of noncognitive behavioral symptoms. Neuropathologically, the cardinal features of AD include neuritic plaques, neuro-fibrillary tangles, and the loss of synapses and neurons. The clinical evaluation of AD includes a history and physical examination, laboratory tests, and structural brain imaging to exclude less common forms of dementia. The clinical management of AD includes medication and nonmedication strategies for addressing cognitive, behavioral, and other commonly associated symptoms of patients as well as lifestyle changes such as driving cessation and residential care. Genetic causes of familial Alzheimer's disease as well as genes that predispose to late-onset and sporadic Alzheimer's disease have led to greater understanding of the pathophysiology of the neurodegenerative process.
Conclusions: While there has been great promise in the scientific understanding, early detection, and tracking of AD and in the discovery of promising disease-slowing treatments, there remains an unmet urgent need to identify effective primary and secondary prevention therapies in order to avert a financially overwhelming public health problem.
Comment in
-
A 100-year update on Alzheimer's disease and related disorders.J Clin Psychiatry. 2006 Nov;67(11):1782-3. doi: 10.4088/jcp.v67n1117. J Clin Psychiatry. 2006. PMID: 17196060 No abstract available.
Similar articles
-
Dementia -- Caring, Ethics, Ethnical and Economical Aspects: A Systematic Review [Internet].Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun. SBU Assessment No. 172. PMID: 28876770 Free Books & Documents. Review.
-
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.Lancet Neurol. 2017 Jan;16(1):55-65. doi: 10.1016/S1474-4422(16)30291-5. Lancet Neurol. 2017. PMID: 27979356 Free PMC article.
-
Alzheimer's disease.Dis Mon. 1992 Jan;38(1):1-64. doi: 10.1016/0011-5029(92)90010-m. Dis Mon. 1992. PMID: 1727391 Review.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.Neurology. 2005 Mar 8;64(5):834-41. doi: 10.1212/01.WNL.0000152982.47274.9E. Neurology. 2005. PMID: 15753419
Cited by
-
Therapeutic application of neural stem cells and adult neurogenesis for neurodegenerative disorders: regeneration and beyond.Eur J Neurodegener Dis. 2012;1(3):335-351. Eur J Neurodegener Dis. 2012. PMID: 25729743 Free PMC article.
-
Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease.J Alzheimers Dis. 2012;31(2):335-41. doi: 10.3233/JAD-2012-120508. J Alzheimers Dis. 2012. PMID: 22531418 Free PMC article. Clinical Trial.
-
Cerebrospinal fluid β-amyloid 1-42 correlates with rate of progression in Alzheimer's disease.J Neural Transm (Vienna). 2012 Jul;119(7):799-804. doi: 10.1007/s00702-012-0798-7. Epub 2012 Mar 30. J Neural Transm (Vienna). 2012. PMID: 22460296
-
Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow.Am J Pathol. 2010 Jul;177(1):346-54. doi: 10.2353/ajpath.2010.090840. Epub 2010 Jun 3. Am J Pathol. 2010. PMID: 20522650 Free PMC article.
-
Confounding.Indian J Psychiatry. 2007 Apr;49(2):129-31. doi: 10.4103/0019-5545.33263. Indian J Psychiatry. 2007. PMID: 20711398 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical